Radiomics predicts response of individual HER2 ‐amplified colorectal cancer liver metastases in patients treated with HER2 ‐targeted therapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Radiomics predicts response of individual HER2 ‐amplified colorectal cancer liver metastases in patients treated with HER2 ‐targeted therapy

Published:2020-09-14 Issue:11 Volume:147 Page:3215-3223
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Giannini Valentina¹²^ORCID,Rosati Samanta³^ORCID,Defeudis Arianna¹²,Balestra Gabriella³,Vassallo Lorenzo⁴,Cappello Giovanni¹,Mazzetti Simone¹²,De Mattia Cristina⁵,Rizzetto Francesco⁶,Torresin Alberto⁵⁷,Sartore‐Bianchi Andrea⁸⁹^ORCID,Siena Salvatore⁸⁹^ORCID,Vanzulli Angelo⁶⁸,Leone Francesco¹⁰¹¹,Zagonel Vittorina¹²,Marsoni Silvia¹³,Regge Daniele¹²

Affiliation:

1. Radiology Unit Candiolo Cancer Institute, FPO‐IRCCS Candiolo Italy

2. Department of Surgical Sciences University of Turin Turin Italy

3. Department of Electronics and Telecommunications Polytechnic of Turin Turin Italy

4. Radiology Unit SS Annunziata Savigliano Hospital Cuneo Italy

5. Department of Medical Physics ASST Grande Ospedale Metropolitano Niguarda Milan Italy

6. Department of Radiology ASST Grande Ospedale Metropolitano Niguarda Milan Italy

7. Department of Physics Università degli Studi di Milano Milan Italy

8. Department of Oncology and Hemato‐Oncology Università degli Studi di Milano Milan Italy

9. Niguarda Cancer Center Grande Ospedale Metropolitano Niguarda Milan Italy

10. Medical Oncology ASL Biella Biella Italy

11. Department of Oncology University of Turin Turin Italy

12. Medical Oncology Unit 1 Istituto Oncologico Veneto‐IRCCS Padova Italy

13. Precision Oncology IFOM‐The FIRC Institute of Molecular Oncology Milan Italy

Funder

Associazione Italiana per la Ricerca sul Cancro

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ijc.33271

Reference35 articles.

1. Tumor Heterogeneity in Primary Colorectal Cancer and Corresponding Metastases. Does the Apple Fall Far From the Tree?

2. Pertuzumab plus trastuzumab for HER2-amplified metastatic colorectal cancer (MyPathway): an updated report from a multicentre, open-label, phase 2a, multiple basket study

3. Dual-targeted therapy with trastuzumab and lapatinib in treatment-refractory, KRAS codon 12/13 wild-type, HER2-positive metastatic colorectal cancer (HERACLES): a proof-of-concept, multicentre, open-label, phase 2 trial

4. Radiologic and Genomic Evolution of Individual Metastases during HER2 Blockade in Colorectal Cancer

5. Radiological heterogeneity in response to chemotherapy is associated with poor survival in patients with colorectal liver metastases

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Possibilities and prospects of artificial intelligence in the treatment of colorectal cancer (review);Koloproktologia;2024-06-21

2. Radiomic Parameters for the Evaluation of Response to Treatment in Metastatic Colorectal Cancer Patients with Liver Metastasis: Findings from the CAVE-GOIM mCRC Phase 2 Trial;Clinical Drug Investigation;2024-06-17

3. Artificial Intelligence Applications in the Treatment of Colorectal Cancer: A Narrative Review;Clinical Medicine Insights: Oncology;2024-01

4. Multiparametric MRI-based radiomics combined with pathomics features for prediction of the efficacy of neoadjuvant chemotherapy in breast cancer;Heliyon;2024-01

5. Artificial intelligence across oncology specialties: current applications and emerging tools;BMJ Oncology;2024-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3